Dermatologie

33. Morris A. Cellulitis and erysipelas. BMJ Clinical Evidence [online] 2006 [cited Dec 20].www.clinicalevidence.com34. Prodigy guidance. Cellullitis. Oct 2006. www.prodigy.nhs.uk)35. CREST Guidelines on the management of cellulitis in adults. June 2005 www.crestni.org.uk36. von den Driesch P. Candidiasis. Evidence Based Dermatology. BMJ Books. April 2003, p. 490-500.37. Dekker J, Boeke A, Gercama A et al. NHG-standaard Fluor vaginalis. Huis Wetensch2005;48(9):459-66.38. Répertoire Commmenté des Médicaments 2006. Centre Belge d’InformationPharmacothérapeutique. www.cbip.be39. De Kock C, Duyvendak R, Jaspar A et al. NHG-Standaard dermatomycosen.http://nhg.artsennet.nl/standaarden/M64/start.htm40. Dermatomycosen. Farmacotherapeutisch Kompas 2006, p. 593-8. www.fk.cvz.nl41. Prodigy guidance. Fungal (dermatophyte) skin infections. May 2006 www.prodigy.nhs.uk42. Crawford F. Athlete’s foot. BMJ Clinical Evidence [online] 2006 [cited Dec 20].www.clinicalevidence.com43. Prodigy guidance. Fungal and candidal nail infection. May 2006. www.prodigy.nhs.uk44. Amabile C, Spencer A. Keeping your patient with heart failure safe: a review of potentially dangerousmedications. Arch Intern Med 2004;164:709-20.45. Johnstone P, Strong M. Scabies. BMJ Clinical Evidence [online] 2006 [cited Dec 20].www.clinicalevidence.com46. Prodigy Guidance – Scabies. Oct 2005. www.prodigy.nhs.uk47. Cullum N, Petherick E. Pressure ulcers. BMJ Clinical Evidence [online] 2006 [cited dec 20].www.clinicalevidence.com48. Schweitzer BPM, Doorenbosch J, Glotzbach R et al. NHG-Standaard Ulcus cruris venosum.http://nhg.artsennet.nl/standaarden/M16/start.htm49. Nelson EA, Cullum N, Jones J. Venous leg ulcers. BMJ Clinical Evidence [online] 2006 [cited Dec20]. www.clinicalevidence.com50. Richtlijn Diagnostiek en behandeling van het ulcus cruris venosum. Nederlandse Vereniging voorDermatologie en Venerologie, 2005.www.cbo.nl/product/richtlijnen/folder20021023121843/rl_ulcuscruris_2005.pdf/view51. The management of pressure ulcers in primary and secondary care. A clinical practice guideline.Royal College of Nursing 2005. www.rcn.org.uk52. Chel V, Germs P, Van der Wal J et al. NHG-Standaard decubitus.http://nhg.artsennet.nl/standaarden/M70/start.htm53. Moore Z, Cowman S. Wound cleansing for pressure ulcers. Cochrane Database of SystematicReviews 2005, Issue 4. Art. No.: CD004983. DOI: 10.1002/14651858.CD004983.pub2.)54. Bergin S, Wraight P. Silver based wound dressings and topical agents for treating diabetic footulcers. The Cochrane Database of Systematic Reviews 2006, Issue 1. Art.No.: CD005082.pub2.DOI:10.1002/14651858.CD005082.pub2.55. Finnish Medical Society Duodecim. Psoriasis. In: EBM Guidelines. Evidence-Based MedicineHelsinki Finland. May 200556. Naldi L, Rzany B. Psoriasis (chronic plaque). BMJ Clinical Evidence [online] 2006 [cited Dec 20].www.clinicalevidence.com57. Anonymous. Cancers cutanés après puvathérapie. La Revue Prescrire 2005;261:353.58. Anonymous. Psoriasis des adultes. Des rémissions, mais pas de traitement curatif. Revue Prescrire2005;25:751-62.59. Anonymous. Analogues de la vitamine D en cas de psoriasis. Folia Pharmacotherapeutica2003;30:7-8. www.cbip.be60. Van Hecke E. Calcipotriol voor chronische plaque psoriasis. Minerva (Huisarts Nu) 2002;32:378-80.http://www.minerva-ebm.be/articles/nl/pdf_2002/7-2002_kort_calcipotriol.pdf61. Lantinga H, Ek J, Nijman F et al. NHG-Standaard Psoriasis (tweede herziening).http://nhg.artsennet.nl/upload/104/standaarden/M39/start.htm62. Bruner C, Feldman S, Ventrapragada M et al. A systematic review of adverse effects associated withtopical treatments for psoriasis. Dermatol Online J 2003,9:263. Afifi T, de Gannes G, Huang C et al. Topical therapies for psoriasis: evidence-based review. CanFam Physician 2005;51:519-25.64. Scottisch Medicines Consortium Calcipotriol/betamethasone dipropionate ointment. Dec 2005.www.scottishmedicines.org.ukDermatologie 427